Lourdes Valera

1.6k total citations
23 papers, 1.3k citations indexed

About

Lourdes Valera is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Lourdes Valera has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Lourdes Valera's work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Lourdes Valera is often cited by papers focused on Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Lourdes Valera collaborates with scholars based in United States, Germany and France. Lourdes Valera's co-authors include Robert A. Fridell, Chunfu Wang, Dike Qiu, Min Gao, Donald R. O’Boyle, Peter T. Nower, Jin-Hua Sun, J Fung-Tomc, D P Bonner and Elizabeth Gradelski and has published in prestigious journals such as Hepatology, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

Lourdes Valera

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lourdes Valera United States	18	895	836	500	186	172	23	1.3k
Anita Y. M. Howe United States	20	709 0.8×	654 0.8×	542 1.1×	25 0.1×	178 1.0×	29	1.3k
Jenny C. Yang United States	16	410 0.5×	565 0.7×	122 0.2×	283 1.5×	130 0.8×	24	1.0k
Howard Mayer United States	13	111 0.1×	434 0.5×	1.0k 2.1×	228 1.2×	155 0.9×	15	1.7k
M. Azim Ansari United Kingdom	21	360 0.4×	509 0.6×	484 1.0×	17 0.1×	447 2.6×	61	1.4k
Vickie Brown‐Driver United States	13	126 0.1×	209 0.3×	228 0.5×	56 0.3×	484 2.8×	14	863
Aesop Cho United States	15	162 0.2×	254 0.3×	450 0.9×	54 0.3×	326 1.9×	24	906
Inge Vliegen Belgium	19	408 0.5×	592 0.7×	278 0.6×	60 0.3×	341 2.0×	33	1.4k
Shinji Maeda Japan	19	113 0.1×	961 1.1×	840 1.7×	30 0.2×	195 1.1×	71	1.3k
James J. Kohler United States	20	137 0.2×	262 0.3×	559 1.1×	27 0.1×	283 1.6×	37	1.2k
Siem de Marie Netherlands	16	54 0.1×	861 1.0×	1.1k 2.3×	82 0.4×	89 0.5×	20	1.5k

Countries citing papers authored by Lourdes Valera

Since Specialization

Citations

This map shows the geographic impact of Lourdes Valera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lourdes Valera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lourdes Valera more than expected).

Fields of papers citing papers by Lourdes Valera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lourdes Valera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lourdes Valera. The network helps show where Lourdes Valera may publish in the future.

Co-authorship network of co-authors of Lourdes Valera

This figure shows the co-authorship network connecting the top 25 collaborators of Lourdes Valera. A scholar is included among the top collaborators of Lourdes Valera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lourdes Valera. Lourdes Valera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Chunfu, Lingling Jia, Donald R. O’Boyle, et al.. (2014). Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity. Antimicrobial Agents and Chemotherapy. 58(9). 5155–5163. 54 indexed citations

Wang, Chunfu, Jin-Hua Sun, Donald R. O’Boyle, et al.. (2013). Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir. Antimicrobial Agents and Chemotherapy. 57(5). 2054–2065. 80 indexed citations

Belema, Makonen, Van N. Nguyen, Denis R. St. Laurent, et al.. (2013). HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives. Bioorganic & Medicinal Chemistry Letters. 23(15). 4428–4435. 11 indexed citations

O’Boyle, Donald R., Peter T. Nower, Jin-Hua Sun, et al.. (2013). A 96-well based analysis of replicon elimination with the HCV NS5A replication complex inhibitor daclatasvir. Journal of Virological Methods. 193(1). 68–76. 4 indexed citations

Lopez, Omar D., Van N. Nguyen, Denis R. St. Laurent, et al.. (2012). HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies. Bioorganic & Medicinal Chemistry Letters. 23(3). 779–784. 23 indexed citations

Sun, Jin-Hua, Donald R. O’Boyle, Yan Zhang, et al.. (2012). Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052. Hepatology. 55(6). 1692–1699. 41 indexed citations

Fridell, Robert A., et al.. (2012). Intragenic Complementation of Hepatitis C Virus NS5A RNA Replication-Defective Alleles. Journal of Virology. 87(4). 2320–2329. 30 indexed citations

Wang, Chunfu, et al.. (2012). In Vitro Activity of Daclatasvir on Hepatitis C Virus Genotype 3 NS5A. Antimicrobial Agents and Chemotherapy. 57(1). 611–613. 40 indexed citations

Fridell, Robert A., Dike Qiu, Lourdes Valera, et al.. (2011). Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052. Journal of Virology. 85(14). 7312–7320. 114 indexed citations

10.

Fridell, Robert A., Chunfu Wang, Jin-Hua Sun, et al.. (2010). Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations. Hepatology. 54(6). 1924–1935. 186 indexed citations

11.

Fridell, Robert A., Dike Qiu, Chunfu Wang, Lourdes Valera, & Min Gao. (2010). Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System. Antimicrobial Agents and Chemotherapy. 54(9). 3641–3650. 225 indexed citations

12.

Yigit, Hesna, Gregory J. Anderson, James W. Biddle, et al.. (2002). Carbapenem Resistance in a Clinical Isolate of Enterobacter aerogenes Is Associated with Decreased Expression of OmpF and OmpC Porin Analogs. Antimicrobial Agents and Chemotherapy. 46(12). 3817–3822. 54 indexed citations

13.

Fung-Tomc, J, Elizabeth Gradelski, Lourdes Valera, E Huczko, & D P Bonner. (2002). Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species. International Journal of Antimicrobial Agents. 20(1). 57–60. 8 indexed citations

14.

Gradelski, Elizabeth, Lourdes Valera, B Kolek, D P Bonner, & J Fung-Tomc. (2001). Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and β-lactams. International Journal of Antimicrobial Agents. 18(1). 43–48. 13 indexed citations

15.

Gradelski, Elizabeth, Lourdes Valera, Lauren M. Aleksunes, D P Bonner, & J Fung-Tomc. (2001). Correlation between Genotype and Phenotypic Categorization of Staphylococci Based on Methicillin Susceptibility and Resistance. Journal of Clinical Microbiology. 39(8). 2961–2963. 46 indexed citations

16.

Gradelski, Elizabeth, Lourdes Valera, D P Bonner, & J Fung-Tomc. (2001). Synergistic Activities of Gatifloxacin in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa and Related Species. Antimicrobial Agents and Chemotherapy. 45(11). 3220–3222. 14 indexed citations

17.

Gradelski, Elizabeth, B Kolek, D P Bonner, et al.. (2001). Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents. International Journal of Antimicrobial Agents. 17(2). 103–107. 34 indexed citations

18.

Fung-Tomc, J, Elizabeth Gradelski, Lourdes Valera, B Kolek, & D P Bonner. (2000). Comparative Killing Rates of Fluoroquinolones and Cell Wall-Active Agents. Antimicrobial Agents and Chemotherapy. 44(5). 1377–1380. 23 indexed citations

19.

Huczko, E, et al.. (2000). Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997–1998. International Journal of Antimicrobial Agents. 16(4). 401–405. 21 indexed citations

20.

Fung-Tomc, J, Beatrice Minassian, B Kolek, et al.. (2000). Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756. Antimicrobial Agents and Chemotherapy. 44(12). 3351–3356. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact